| |||||||||

Revenue by Geography (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Asia-Pacific | 0 | 0 | 0 | 0 | 2.06B | |||
| Revenue - Latin America | 782M | 884M | 990M | 1.36B | 0 | |||
| Revenue - International | 5.05B | 5.92B | 6.40B | 8.09B | 0 | |||
| Revenue - US | 3.22B | 3.59B | 4.19B | 4.60B | 0 | |||
| Total Revenue | 8.27B | 9.51B | 10.6B | 12.7B | 18.5B | |||
Revenue by Segment (USD) Annual | ||||||||
|---|---|---|---|---|---|---|---|---|
| FISCAL YEAR ENDING |
|
31-DEC 2004 |
31-DEC 2005 |
31-DEC 2006 |
31-DEC 2007 |
31-DEC 2008 |
||
| Revenue - Consumer Health Care | 0 | 0 | 0 | 0 | 1.28B | |||
| Revenue - Animal Health | 0 | 0 | 0 | 0 | 2.97B | |||
| Revenue - Remicade | 0 | 0 | 0 | 0 | 2.12B | |||
| Revenue - Other Pharmaceutical | 0 | 0 | 0 | 0 | 4.45B | |||
| Revenue - NASONEX | 0 | 0 | 0 | 0 | 1.16B | |||
| Revenue - TEMODAR | 0 | 0 | 0 | 0 | 1.00B | |||
| Revenue - RPEGINTRON | 0 | 0 | 0 | 0 | 914M | |||
| Revenue - CLARINEX/AERIUS | 0 | 0 | 0 | 0 | 790M | |||
| Revenue - FOLLISTIM/PUREGON | 0 | 0 | 0 | 0 | 577M | |||
| Revenue - NUVARING | 0 | 0 | 0 | 0 | 440M | |||
| Revenue - CLARITIN Rx | 0 | 0 | 0 | 0 | 425M | |||
| Revenue - AVELOX | 0 | 0 | 0 | 0 | 376M | |||
| Revenue - INTEGRILIN | 0 | 0 | 0 | 0 | 314M | |||
| Revenue - CAELYX | 0 | 0 | 0 | 0 | 297M | |||
| Revenue - REBETOL | 0 | 0 | 0 | 0 | 260M | |||
| Revenue - ZEMURON | 0 | 0 | 0 | 0 | 253M | |||
| Revenue - REMERON | 0 | 0 | 0 | 0 | 239M | |||
| Revenue - INTRON A | 0 | 0 | 0 | 0 | 234M | |||
| Revenue - SUBUTEX/SUBOXONE | 0 | 0 | 0 | 0 | 230M | |||
| Revenue - ASMANEX | 0 | 0 | 0 | 0 | 180M | |||
| Total Revenue | 8.27B | 9.51B | 10.6B | 12.7B | 18.5B | |||
| ||||||